BC Investments IV, linked to Bain Capital, is expected to sell a 2.4% stake in Emcure Pharmaceuticals. The sale will occur through a block deal valued at Rs 551 crore. About 45.5 lakh shares will be sold at Rs 1,279.80 each. Kotak Securities is managing the deal. Emcure's stock is currently below its all-time high despite strong quarterly results.